R
Rimidi
Rimidi- Serious Hope for Healthcare
About Rimidi
Rimidi operates in the healthcare technology sector, offering cloud-based clinical decision support and remote patient monitoring solutions. The company primarily serves healthcare providers, including clinicians and medical institutions, focusing on chronic disease management such as diabetes, cardiovascular disease, heart failure, nonalcoholic fatty liver disease, and obesity. Rimidi's platform integrates seamlessly into existing clinical workflows, providing personalized treatment recommendations and medication modeling based on aggregated patient data. This data-driven approach helps clinicians identify patients at high risk for worsening conditions or complications, enabling timely interventions. Rimidi's business model revolves around a subscription-based service, where healthcare providers pay for access to the platform and its various features. The company generates revenue through these subscriptions and potentially through additional services such as data analytics and custom integrations.
Source: Dealroom company dataAt a glance
- Founded
- 2012
- Headquarters
- Atlanta, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Village Capital
Venturewell
Tivity Health
Series A3 investors entered at this stage
Eli Lilly
The JumpFund
Turner Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rimidi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rimidi on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.